Regulation of TCR-induced IFN-γ release from islet-reactive non-obese diabetic CD8+ T cells by prostaglandin E2 receptor signaling

International Immunology

Volumn 12, Issue 6, 2000, Pages 851-860

  Ganapathy, Vidya ^a   Gurlo, Tatyana ^a   Jarstadmarken, Hilde O ^a   Von Grafenstein, Hermann ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cell cell interactions; Cytokine; Cytotoxic T lymphocyte; Diabetes; Rodent

Indexed keywords

CD8 ANTIGEN; CYCLIC AMP; GAMMA INTERFERON; INTERLEUKIN 2; PROSTAGLANDIN E RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CULTURE MEDIUM; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DIABETES MELLITUS; IMMUNE RESPONSE; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYCLIC AMP; DIABETES MELLITUS, TYPE 1; DINOPROSTONE; INTERFERON TYPE II; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, PROSTAGLANDIN E;

EID: 0034047940     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.6.851     Document Type: Article

References (61)

1. Atkinson, M. A. and Maclaren, N. K. 1994. The pathogenesis of insulin-dependent diabetes mellitus. N. Engl J. Med. 331:1428.
2. Bach, J. F. and Mathis, D. 1997. Organizers, The NOD mouse, 70th Forum in Immunol. Res. Immunol. 148:285.
3. Bach, J. F., Chatenoud, L., Herbelin, A., Gombert, J. M. and Carnaud, C. 1997. Autoimmune diabetes: how many steps for one disease? Res, Immunol. 148:332.
4. Katz, J. D., Benoist, C. and Mathis, D. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268:1185.
5. Rabinovitch, A. 1998. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab. Rev. 14:129.
6. 2 protects against liver injury after Escherichia coli infection but hampers the resolution of the infection in mice. J. Immunol. 161:3019.
7. + T cells to suppress recognition of allogeneic and syngeneic MHC class II molecules. J. Leuk. Biol. 52:661.
8. Young, M. R., Wright, M. A., Lozano, Y. Matthews, J. P., Benefield, J. and Prechel, M. M. 1996. Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer. Int. J. Cancer 67:333.
9. Khoury, S. J., Hancock, W. W. and Weiner, H. L. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1355.
10. Rabinovitch, A., Baquerizo, H. and Sumoski, W. 1990. Cytotoxic effects of cytokines on islet beta-cells: evidence for involvement of eicosanoids. Endocrinology 126:67.
11. Hancock, W. W., Polanski, M., Zhang, J., Blogg, N. and Weiner, H. L. 1995. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. Am. J. Pathol. 147:1193.
12. + T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5. J. Immunol. 155:4604.
13. Rothe, H. and Kolb, H. 1998. The APC1 concept of type I diabetes. Autoimmunity 27:179.
14. h2 lymphokines. J. Immunol. 146:108.
15. 2 critically depends on interleukin-2. Eur. J. Immunol. 25:59.
16. Cerwenka, A., Carter, L. L., Reome, J. B., Swain, S. L. and Dutton, R. W. 1998. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J. Immunol. 161:97.
17. Rabinovitch, A., Suarez Pinzon, W. L., Sorensen, O., Bleackley, R. C. and Power, R. F. 1995. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol. 154:4874.
18. + T cells: involvement of a nitric oxide-dependent pathway. J Immunol. 163:5770.
19. 2 inhibits IL-2 and IL-4-dependent proliferation of CTLL-2 and HT2 cells. Cytokine 10:265.
20. Narumiya, S. 1997. Molecular diversity of prostanoid receptors; subtypes and isoforms of prostaglandin E receptor. Adv. Exp. Med. Biol. 400A:207.
21. 4 subtype. FEBS Lett. 364:339.
22. 3 subtype. Adv. Prostaglandin Thromboxane Leukotriene Res. 23:255.
23. s through interaction of alpha-carboxylic acid of agonist and arginine residue of seventh transmembrane domain. J. Biol. Chem. 270:16122.
24. 2 inhibits the nuclear transcription of the human interleukin 2, but not the II-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT. Cell. Immunol. 171:95.
25. Ichikawa, A., Sugimoto, Y. and Negishi, M. 1996. Molecular aspects of the structures and functions of the prostaglandin E receptors. J. Lipid Mediators Cell Signal. 14:83.
26. 3 subtype in cDNA-transfected Chinese hamster ovary cells. Biochim. Biophys. Acta 1244:41.
27. Coleman, R. A., Smith, W. L. and Narumiya, S. 1994. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46:205.
28. Negishi, M., Sugimoto, Y. and Ichikawa, A. 1995. Prostaglandin E receptors. J. Lipid Mediators Cell Signal. 12:379.
29. 2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways J. Exp. Med. 178:1813.
30. Campbell, P. M., Pimm, J., Ramassar, V. and Halloran, P. F. 1996. Identification of a calcium-inducible, cyclosporine sensitive element in the IFN-gamma promoter that is a potential NFAT binding site Transplantation 61:933.
31. Sica, A., Dorman, L., iggiano, V., Cippitelli, M., Ghosh, P., Rice, N. and Young, H. A. 1997. Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J. Biol. Chem 272:30412.
32. Dubey, C., Croft, M. and Swain, S. L. 1996. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals J. Immunol. 157:3280.
33. Powell, J. D., Ragheb, J. A., Kitagawa-Sakakida, S. and Schwartz, R. H. 1998. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy. Immunol. Rev. 165:287.
34. Pawelec, G., Sayers, T. and Busch, F. W. 1989. Selective inhibition of interleukin 2 but not of interferon-gamma, tumour necrosis factor-alpha or granulocyte/macrophage colony stimulating factor secretion by human helper T cell clones after antigen-driven tolerisation. Immunol. Lett. 20:187.
35. O Hehir, R. E., Yssel, H., Verma, S., de Vries, J. E., Spits, H. and Lamb, J. R. 1991. Clonal analysis of differential lymphokine production in peptide and superantigen induced T cell anergy. Int. Immunol. 3:819.
36. Futaki, N., Takahashi, S., Yokoyama. M., Arai, I., Higuchi, S. and Otomo, S. 1994. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47:55.
37. Karasuyama, H. and Melchers, F. 1988. Establishment of mouse cell lines which constitutively produce large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
38. Agostino, M., Prowse, S. J. and Lafferty, K. J. 1982. Resistance of established islet allografts to rejection by antibody and complement. Aust. J. Exp. Biol. Med. Sci. 60:219.
39. Powell, W. S. 1982. Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica. Methods Enzymol. 86:467.
40. Hamaguchi, K., Gaskins, H. R. and Leiter, E. H. 1991. NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes 40:842.
41. 3 subtype. J. Biol. Chem. 267:6463.
42. Maxwell, S. E. and Delaney, H. D. 1990. Designing Experiments and Analyzing Data: A Model Comparison Perspective. Wadsworth, Belmont, CA.
43. Kiriyama, M., Ushikubi, F., Kobayashi, T., Hirata, M., Sugimoto, Y. and Narumiya, S. 1997. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br. J. Pharmacol. 122:217.
44. 2-receptor agonist. Prostaglandins 46:371.
45. + T cell interactions in IFN-gamma and IL-4 responses to viral infections: requirements for IL-2. J. Immunol. 160:5007.
46. + T cell subset. Eur. J. Immunol. 28:3630.
47. Viola, A. and Lanzavecchia, A. 1996. T cell activation determined by T cell receptor number and tunable thresholds [see comments]. Science 273:104.
48. Narumiya, S. 1994. Prostanoid receptors. Structure, function, and distribution. Ann. NY Acad. Sci. 744:126.
49. Li, L., Yee, C. and Beavo, J. A. 1999. CD3- and CD28-dependent induction of PDE7 required for T cell activation. Science 283:848.
50. Tsuruta, L., Lee, H. J., Masuda, E. S., Koyano-Nakagawa, N., Arai, N. Arai, K. and Yokota, T. 1995. Cyclic AMP inhibits expression of the IL-2 gene through the nuclear factor of activated T cells (NF-AT) site, and transfection of NF-AT cDNAs abrogates the sensitivity of EL-4 cells to cyclic AMP J. Immunol 154:5255.
51. Sheridan, C. M. and Gardner, P. 1998. Paper presented at Gordon Research Conference. In Gordon Research Conference. Kimball Union, NH.
52. Gesbert, F., Delespine-Carmagnat, M. and Bertoglio, J. 1998. Recent advances in the understanding of interleukin-2 signal transduction. J. Clin. Immunol. 18:307.
53. Andre, I., Gonzalez, A., Wang, B., Katz, J., Benoist, C. and Mathis, D. 1996. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl Acad. Sci. USA 93:2260.
54. Gazda, L. S., Charlton, B. and Lafferty, K. J. 1997. Diabetes results from a late change in the autoimmune response of NOD mice. J. Autoimmun. 10:261.
55. Croft, M., Carter, L., Swain, S. L. and Dutton, R. W. 1994. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180:1715.
56. + T cells of non-obese diabetic mice. J. Immunol. 151:1723.
57. + suppressor cells. J. Immunol. 139:688.
58. + lymphocytes. J. Clin. Invest. 83:1436.
59. 2 enhancement of interferon-gamma production by antigen-stimulated type 1 helper T cells. Cell. Immunol. 194:21.
60. 2 receptors during human T cell activation. Cell. Immunol. 134:287.
61. 2 regulation of the immune response. Adv. Prostaglandin. Thromboxane. Leukothene Res. 22:101.